Formoterol Fumarate Inhalation Powder Articles
Almirall starts Ph III COPD trial; collaborates with BioFocus; and posts sales and earnings downturn
16 November 2011
SkyePharma/Novartis' Foradil Certihaler launched in Germany
12 September 2005
SkyePharma sees net loss fall for 1st-half 2004, as sales rise and R&D costs decrease
20 September 2004
First Euro appro for Skye/Novartis' Foradil
15 March 2004
Novartis inhaler filing boosts SkyePharma
6 January 2003
Novartis' Foradil cleared for COPD in USA; new data on Xolair
27 September 2001
Foradil gets OK for maintenance in USA
19 February 2001
Showing 1-8 of 8 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
